Part 14 – 24/7 Autonomous Journal Article Updating System (AJAUS):
Integrated Architecture
(AJAUS + OpenClaw + NemoClaw)
Curator: Aviva Lev-Ari, PhD, RN | Updated March 2026
1. Original AJAUS Concept (from Slide #19)
The Autonomous Journal Article Updating System (AJAUS) was originally designed as a hybrid human + Grok system to enable continuous, traceable updates of LPBI journal articles while maintaining human expert oversight. Its core purpose is to keep our 6,283 journal articles, 48 e-Books, and other trainable assets continuously updated with new scientific findings while maintaining causal reasoning and traceability.
Original AJAUS Concept (Slide #19):
Hybrid Human + Grok Workflow
HUMAN EXPERT (CEO / Final Approval)
│
▼
AJAUS Orchestration Layer
│
┌──────────────────┴──────────────────┐
│ │
Data Ingestion Content Validation
(New papers, Scoop.it, (Ontology check,
PubMed, Categories) Causal Reasoning)
│ │
└──────────────────┬──────────────────┘
│
▼
Article Update Engine
(Grok Causal Reasoning +
COM Part 13 SLM-to-LLM)
│
▼
Human-in-the-Loop Review
│
▼
PUBLISHED UPDATED ARTICLE
(Version History + Traceability)2. Original Detailed Workflow (from Appendix #19)
Original AJAUS Detailed Workflow (Pre-NemoClaw):
HUMAN EXPERT (CEO)
│
▼
AJAUS Core Engine (COM Parts 10–13)
│
┌──────────────────┴──────────────────┐
│ │
Step 1: Data Selection Step 2: Validation Models
(AJAUS Module 1–6) (Module 7–12)
• New papers / Scoop.it • Ontology alignment
• Category matching • Causal consistency
• Expert-selected datasets • Quality scoring
│ │
└──────────────────┬──────────────────┘
│
▼
Step 3: Update & Augmentation
(Grok Causal Reasoning +
SLM-to-LLM Transition – Part 13)
│
▼
Step 4: Human Review & Approval
│
▼
PUBLISHED UPDATED ARTICLE
(with full traceability and version history)3. New Multi-Agent Architecture (AJAUS + NemoClaw Integration)
To evolve AJAUS into a true 24/7 autonomous system, we integrate NVIDIA NemoClaw, an open-source multi-agent orchestration framework. This creates a hierarchical team of specialized AI agents coordinated by a “Chief of Staff” agent.
3.1 High-Level Architecture Diagram: AJAUS + NemoClaw
Foundation for the 2026 multi-agent enhancement with OpenClaw/NemoClaw
HUMAN EXPERT (CEO)
│
▼
CHIEF OF STAFF AGENT
(OpenClaw Orchestrator + Memory Layer)
│
┌──────────────────┴──────────────────┐
│ │
DISCORD CHANNEL PERSISTENT MEMORY
(Real-time Alerts & Notifications) (Markdown + Learning Log)
│
▼
┌───────────────────────────────────────────────────────┐
│ AGENT TEAM (OpenClaw) │
└───────────────────────────────────────────────────────┘
│
┌────────────┼────────────┬────────────┬────────────┬────────────┐
│ │ │ │ │ │
Research Validation Update Quality Deployment Human-in-
Agent Agent Agent Agent Agent the-Loop
│ │ │ │ │ Approval
└────────────┴────────────┴────────────┴────────────┘
│
▼
UPDATED JOURNAL ARTICLE
(Published + Traceable + Version History)3.2 New Orchestration Capabilities Inspired by Leading Agentic Systems (March 2026)
Building on the core AJAUS + NemoClaw architecture, we incorporate advanced orchestration principles recently highlighted by Perplexity CEO Aravind Srinivas. The system evolves from instruction-driven to objective-driven orchestration, where the Chief of Staff agent receives a high-level goal and dynamically decomposes, routes, and executes the workflow.
Key New Orchestration Features:
- Dynamic Multi-Model Routing + Model Council
- Hybrid Local/Server Execution with Privacy Controls
- Advanced Context Management for Long-Running Workflows
- Clear Sub-Agent Specialization and Hand-Off Protocols
These enhancements make AJAUS a true AI Computer for biomedical knowledge management — autonomous, scalable, and clinically reliable.[1]
Footnote [1] Perplexity CEO Aravind Srinivas on agentic orchestration: https://youtu.be/-JBhTBu9ZbA
Updated AJAUS + NemoClaw Orchestration Layer
(March 2026 Enhancement)
HUMAN EXPERT (CEO)
│
▼
CHIEF OF STAFF AGENT
(Objective-Driven Orchestrator + Memory Layer)
│
┌──────────────────┴──────────────────┐
│ │
DISCORD CHANNEL PERSISTENT MEMORY
(Real-time Alerts) (Dynamic Context Mgmt)
│
▼
┌───────────────────────────────────────────────────────┐
│ AGENT TEAM (NemoClaw / OpenClaw) │
└───────────────────────────────────────────────────────┘
│
┌────────────┼────────────┬────────────┬────────────┬────────────┐
│ │ │ │ │ │
Research Validation Update Quality Deployment Model Council
Agent Agent Agent Agent Agent (Dynamic Routing)
│ │ │ │ │
└────────────┴────────────┴────────────┴────────────┘
│
▼
UPDATED JOURNAL ARTICLE
(Published + Traceable + Version History)
Caption: Enhanced orchestration layer incorporating objective-driven routing, multi-model council, hybrid execution, and advanced context management for scalable, autonomous operation.[1]
Footnote [1] Perplexity CEO Aravind Srinivas on agentic orchestration: https://youtu.be/-JBhTBu9ZbA
Our 9 GB corpus, meticulously curated by domain-knowledge experts over 14 years, positions LPBI Group as a premier Healthcare ENGINE for high-quality synthetic data generation. As Mistral CEO Arthur Mensch emphasized, synthetic data is highly efficient for initial model warming-up and compression, but “eventually you do need to have human signal” and “it’s not enough” without it. Our causally structured, high-provenance content — written and validated by PhDs, MDs, and clinical experts — supplies exactly this essential human signal, enabling the generation of superior, clinically accurate synthetic datasets that power reliable agentic AI systems in medicine.
Footnote [2] Mistral CEO Arthur Mensch on synthetic data: https://youtu.be/-JBhTBu9ZbA
4. Key Benefits and Synergy with Existing COM Parts
- Enables true 24/7 autonomous operation with continuous learning
- Combines OpenClaw’s agentic orchestration with AJAUS’s domain-specific causal reasoning
- Directly supports updating all four categories of trainable data assets:
- Five Primary IP Asset Classes (I, II, III, V, X)
- Five Additional Domain-aware Data Repositories/Portals
- 13 Hidden Gems (as ready-made SLMs)
- 15 Small Language Models (SLMs) from “Articles of Note”
- Strengthens COM Parts 10–13 and prepares the system for scalable autonomous updates across the entire LPBI ecosystem
5. Human-in-the-Loop Governance (CEO Role)
The human expert remains the CEO with final approval authority, ensuring scientific integrity while allowing agents to handle routine work.
6. Roadmap for Implementation
- Phase 1: Deploy NemoClaw orchestration layer
- Phase 2: Configure specialized agents using our 13 Gems
- Phase 3: Integrate with existing AJAUS workflows
- Phase 4: Pilot on high-priority domains (Medical Devices 2nd Edition, Respiratory/Infectious Disease)
- Phase 5: Scale across all trainable data assets
Cross-References: See Slide #19 for the original concept and Appendix #19 for detailed technical specifications. This architecture will power future updates of the Medical Devices Gem (2nd Edition) and all 15 Small Language Models.
NemoClaw Announcement by NVIDIA on March 10, 2026
7. AJAUS Prototype
AJAUS Prototype (Flagship of the Tool Factory)
LPBI Group is developing a production prototype of COM Part 14, the flagship 24/7 Autonomous Journal Article Updating System (AJAUS + OpenClaw + NemoClaw). This multi-agent architecture features a Chief of Staff Agent orchestrating specialized Research, Validation, Update, Quality, and Deployment agents, supported by persistent memory and real-time alerting, while maintaining full human-in-the-loop governance.
Phase 1 Pilot (April 2026)
- 40 carefully selected high-value articles focused primarily on cancer as a disease indication
- 4-week controlled 24/7 operation
- Expected outcomes include measurable improvements in update speed, accuracy, discovery of new causal relationships, and significant reduction in human review effort while preserving expert oversight.
Strategic Value The prototype will demonstrate autonomous updating, causal reasoning uplift, and traceability, providing tangible proof of LPBI’s unique data moat for clinical-grade agentic AI in healthcare. It will also serve as the engine for future 2nd Editions of the BioMed e-Series, refreshment of the 13 Hidden Gems, and enhancement of the 15 “Articles of Note” collections for Small Language Models.
Status Design and planning complete. Pilot launch targeted for April 2026.
This page has the following sub pages.
2012pharmaceutical
sjwilliamspa